Shorla raises $35m via Series B to progress oncology product portfolio

Shorla Oncology has raised $35m in a Series B funding round to progress its oncology product portfolio.

Related Keywords

Ireland ,Canada ,Canadian ,Irish ,Daniel Parera ,Sharon Cunningham ,Drug Administration ,Seroba Life Sciences ,Kurma Partner Growth Opportunities Fund ,Enterprise Ireland ,Nelarabine Injection ,Specialty Pharma ,European Healthcare ,Life Science ,